Application of prostacyclin analogue and thromboxane synthetase inhibitor to chronic vascular rejection after kidney transplantation. 1987

S Teraoka, and K Takahashi, and H Toma, and T Sanaka, and Y Yamaguchi, and K Tanabe, and H Sato, and H Kawaguchi, and S Oba, and I Nakajima
Department of Surgery, Tokyo Women's Medical College, Japan.

UI MeSH Term Description Entries
D008689 Methacrylates Acrylic acids or acrylates which are substituted in the C-2 position with a methyl group. Methacrylate
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000179 Acrylates Derivatives of acrylic acid (the structural formula CH2
D013930 Thromboxane-A Synthase An enzyme found predominantly in platelet microsomes. It catalyzes the conversion of PGG(2) and PGH(2) (prostaglandin endoperoxides) to thromboxane A2. EC 5.3.99.5. Thromboxane Synthetase,Thromboxane A Synthase,Thromboxane A2 Synthetase,A2 Synthetase, Thromboxane,Synthase, Thromboxane A,Synthase, Thromboxane-A,Synthetase, Thromboxane,Synthetase, Thromboxane A2
D013988 Ticlopidine An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES. 53-32C,Ticlid,Ticlodix,Ticlodone,Ticlopidine Hydrochloride,53 32C,5332C,Hydrochloride, Ticlopidine
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014652 Vascular Diseases Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body. Disease, Vascular,Diseases, Vascular,Vascular Disease

Related Publications

S Teraoka, and K Takahashi, and H Toma, and T Sanaka, and Y Yamaguchi, and K Tanabe, and H Sato, and H Kawaguchi, and S Oba, and I Nakajima
April 1989, Nihon rinsho. Japanese journal of clinical medicine,
S Teraoka, and K Takahashi, and H Toma, and T Sanaka, and Y Yamaguchi, and K Tanabe, and H Sato, and H Kawaguchi, and S Oba, and I Nakajima
June 1990, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
S Teraoka, and K Takahashi, and H Toma, and T Sanaka, and Y Yamaguchi, and K Tanabe, and H Sato, and H Kawaguchi, and S Oba, and I Nakajima
January 1997, Transplantation proceedings,
S Teraoka, and K Takahashi, and H Toma, and T Sanaka, and Y Yamaguchi, and K Tanabe, and H Sato, and H Kawaguchi, and S Oba, and I Nakajima
January 2020, Transplantation proceedings,
S Teraoka, and K Takahashi, and H Toma, and T Sanaka, and Y Yamaguchi, and K Tanabe, and H Sato, and H Kawaguchi, and S Oba, and I Nakajima
July 2015, Nephrology (Carlton, Vic.),
S Teraoka, and K Takahashi, and H Toma, and T Sanaka, and Y Yamaguchi, and K Tanabe, and H Sato, and H Kawaguchi, and S Oba, and I Nakajima
August 1986, Annals of plastic surgery,
S Teraoka, and K Takahashi, and H Toma, and T Sanaka, and Y Yamaguchi, and K Tanabe, and H Sato, and H Kawaguchi, and S Oba, and I Nakajima
November 1990, Prostaglandins, leukotrienes, and essential fatty acids,
S Teraoka, and K Takahashi, and H Toma, and T Sanaka, and Y Yamaguchi, and K Tanabe, and H Sato, and H Kawaguchi, and S Oba, and I Nakajima
October 2002, Medizinische Klinik (Munich, Germany : 1983),
S Teraoka, and K Takahashi, and H Toma, and T Sanaka, and Y Yamaguchi, and K Tanabe, and H Sato, and H Kawaguchi, and S Oba, and I Nakajima
February 1989, American journal of obstetrics and gynecology,
S Teraoka, and K Takahashi, and H Toma, and T Sanaka, and Y Yamaguchi, and K Tanabe, and H Sato, and H Kawaguchi, and S Oba, and I Nakajima
June 1995, Transplantation proceedings,
Copied contents to your clipboard!